- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04333199
Timely Nudge About Lab Results to Increase myGeisinger Uptake
Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.
The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.
The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Pennsylvania
-
Danville, Pennsylvania, Estados Unidos, 17822
- Geisinger
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Geisinger patient for whom a lab was ordered within 30 days prior to email date
- Patient's lab test result released day before email date
Exclusion Criteria:
- Patient already enrolled in myGeisinger
- Patient has already declined myGeisinger
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
Patients do not receive an email
|
|
|
Experimental: Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
|
Email
Email
|
|
Experimental: Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
|
Email
Email
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Periodo de tiempo: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
Periodo de tiempo: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
|
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
Periodo de tiempo: 1 week post-intervention
|
Email was opened (yes / no)
|
1 week post-intervention
|
|
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
Periodo de tiempo: 1 week post-intervention
|
Link / button to start the enrollment process was clicked (yes / no)
|
1 week post-intervention
|
|
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
Periodo de tiempo: 1 month post-intervention
|
Patient unsubscribed from these email communications (yes / no)
|
1 month post-intervention
|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Periodo de tiempo: 1 month post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 month post-intervention
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2020-0316
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Marco de tiempo para compartir IPD
Criterios de acceso compartido de IPD
Tipo de información de apoyo para compartir IPD
- CÓDIGO_ANALÍTICO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .